calcium channel blockers + thiazide diuretics

This refers to any combination drug or co-prescribing of a **calcium channel blocker** (CCB) and a **thiazide diuretic**, most commonly used for the management of hypertension. These drugs are sometimes provided as separate tablets, but fixed-dose combination products containing both classes exist in some markets. - **Mechanism of Action:** - **Calcium channel blockers** inhibit the influx of calcium ions into vascular smooth muscle and cardiac cells, reducing vascular resistance and lowering blood pressure through vasodilation. - **Thiazide diuretics** block the sodium-chloride symporter in the distal convoluted tubule of the nephron, promoting natriuresis and diuresis to decrease extracellular fluid and blood pressure. The combination provides additive antihypertensive effects due to their complementary mechanisms: CCBs mainly cause vasodilation, while thiazides act through diuresis and reduction of plasma volume[2][4][10]. - This combination is recommended as a first-line or second-line antihypertensive in clinical guidelines, often for patients who require more than one agent to achieve blood pressure control[2][9][10]. - No single unique brand name dominates globally; several fixed-dose combinations specifically using amlodipine (a CCB) and hydrochlorothiazide (a thiazide) exist as generics and under various trademarks, depending on country and manufacturer[7][9]. - Primary indication: Management of **hypertension** in adults.

Other names

calcium channel blocker and thiazide diuretic combination